NEW YORK (
) hit a new 52-week high Wednesday as it is currently trading at $7.54, above its previous 52-week high of $7.44 with 520,863 shares traded as of 10:06 a.m. ET. Average volume has been 1.3 million shares over the past 30 days.
Affymetrix has a market cap of $493.5 million and is part of the
industry. Shares are up 44.3% year to date as of the close of trading on Tuesday.
Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets.
- Practice your AFFX trading strategies and win cash in our stock game.
TheStreet Ratings rates Affymetrix as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that revenues have generally been declining. You can view the full
52-week high stocks
or get investment ideas from our